GFS Advisors’s GoodRx Holdings GDRX Stock Holding History

GFS Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,490	Closed	-$212K	–	162
2021 Q4	$212K	Sell	6,490 -250	-4%	-$10.1K	0.04%	163
2021 Q3	$276K	Hold	6,740	–	–	0.06%	147
2021 Q2	$243K	Hold	6,740	–	–	0.05%	134
2021 Q1	$263K	Hold	6,740	–	–	0.06%	123
2020 Q4	$272K	Buy	+6,740	New	+$310K	0.07%	114

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $795M AUM 5.23% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $3.14B AUM 46.44% 1-Year Est. Return

GFS Advisors's GDRX Position: Q1 2022 in Review

GFS Advisors sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 6,490 shares — an estimated $212K sold.

GFS Advisors first reported a position in GDRX in Q4 2020 and held it in 5 quarters. The position peaked at $276K in Q3 2021. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

GFS Advisors reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
GFS Advisors sold 6,490 GoodRx Holdings shares in Q1 2022, an estimated $212K.
GFS Advisors first reported a position in GoodRx Holdings in Q4 2020 and held it in 5 quarters.
GFS Advisors's GoodRx Holdings position peaked at $276K in Q3 2021.
167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on GFS Advisors's 13F filing for Q1 2022, filed 21 Apr 2022.